(Q34897423)

English

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register (English)

1 reference

Europe PubMed Central

5 August 2017

Gerd-Rüdiger Burmester

8

object named as

Gerd-Rüdiger Burmester

0 references

author name string

Joachim Listing

1

1 reference

Europe PubMed Central

5 August 2017

Anja Strangfeld

2

1 reference

Europe PubMed Central

5 August 2017

Rolf Rau

3

1 reference

Europe PubMed Central

5 August 2017

Jörn Kekow

4

1 reference

Europe PubMed Central

5 August 2017

Erika Gromnica-Ihle

5

1 reference

Europe PubMed Central

5 August 2017

Thilo Klopsch

6

1 reference

Europe PubMed Central

5 August 2017

Winfried Demary

7

1 reference

Europe PubMed Central

5 August 2017

Angela Zink

9

1 reference

Europe PubMed Central

5 August 2017

publication date

5 April 2006

1 reference

Europe PubMed Central

5 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

3

1 reference

Europe PubMed Central

5 August 2017

R66

1 reference

Europe PubMed Central

5 August 2017

https://scigraph.springernature.com/pub.10.1186/ar1933

0 references

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Treatment continuation in patients receiving biological agents or conventional DMARD therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for "near remission" of DAS or single measures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Natural remission in inflammatory polyarthritis: issues of definition and prediction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

The Assessment of Disability: from first to future principles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

8 July 2018

Infections in patients with rheumatoid arthritis treated with biologic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

26 October 2018

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1526636

26 October 2018

Therapeutic criteria in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of physical independence in rheumatoid arthritis: interview data from a representative sample of patients in rheumatologic care

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining remission in rheumatoid arthritis: what is it? Does it matter?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985

1 reference

https://pubmed.ncbi.nlm.nih.gov/16600016

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

5 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34897423&oldid=1605906340"